Geyser
发表于 2025-3-25 06:15:58
Therapeutic Options,sociated with a guarded prognosis, namely, with increased recurrence rate and disease-specific mortality. Nonetheless, the small number of cases precludes the design of clinical trials to assess if a specific therapeutic strategy is valuable for those patients. The clinical challenge increases when
潜移默化
发表于 2025-3-25 09:35:53
Book 2018logical and immunohistochemical aspects. Whenever necessary, namely for differential diagnosis and/or therapy purposes, molecular data are also highlighted. In order to understand the histogenesis of rare lesions and to be able to make a differential diagnosis, the editors use the WHO book for endoc
运动吧
发表于 2025-3-25 14:55:51
nderstanding of thyroid oncology through the study of rare l.This book documents the most important clinicopathological features of rare thyroid tumours with an emphasis (and ample documentation) on their histological and immunohistochemical aspects. Whenever necessary, namely for differential diagn
THROB
发表于 2025-3-25 17:40:00
Introduction,We think this is the right time to publish a book on rare tumours of the thyroid gland for a number of reasons.
推测
发表于 2025-3-25 20:08:39
Rare Familial Tumours,Approximately 3–9% of non-medullary thyroid carcinomas occur on a familial basis . About 5% of these tumours are syndromic, whereas the remaining 95% of all cases of familial non-medullary thyroid carcinomas (FNMTCs) are non-syndromic with less well-defined genetic susceptibility .
品牌
发表于 2025-3-26 03:58:30
http://reply.papertrans.cn/83/8213/821276/821276_26.png
DUCE
发表于 2025-3-26 05:05:59
978-3-319-87021-2Springer International Publishing AG 2018
凹槽
发表于 2025-3-26 11:28:49
http://image.papertrans.cn/r/image/821276.jpg
蔓藤图饰
发表于 2025-3-26 14:55:45
https://doi.org/10.1007/978-3-319-61182-2Papillary Carcinoma; Follicular Carcinoma; Hürthle cells; Hodgkin; Medullary Carcinoma
paleolithic
发表于 2025-3-26 20:14:50
http://reply.papertrans.cn/83/8213/821276/821276_30.png